VIRIDIAN THERAPEUTICS INC's ticker is VRDN and the CUSIP is 92790C104. A total of 106 filers reported holding VIRIDIAN THERAPEUTICS INC in Q3 2022. The put-call ratio across all filers is 0.26 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,119,313 | +208.8% | 333,723 | +378.9% | 0.00% | – |
| Q2 2023 | $1,657,665 | -85.0% | 69,679 | -83.9% | 0.00% | -100.0% |
| Q1 2023 | $11,018,928 | +12.5% | 433,134 | +29.2% | 0.00% | 0.0% |
| Q4 2022 | $9,794,172 | +189.9% | 335,302 | +103.5% | 0.00% | – |
| Q3 2022 | $3,379,000 | +959.2% | 164,758 | +497.3% | 0.00% | – |
| Q2 2022 | $319,000 | -50.6% | 27,583 | -21.0% | 0.00% | – |
| Q1 2022 | $646,000 | +138.4% | 34,929 | +155.0% | 0.00% | – |
| Q4 2021 | $271,000 | +66.3% | 13,695 | +38.0% | 0.00% | – |
| Q3 2021 | $163,000 | +27.3% | 9,922 | +42.0% | 0.00% | – |
| Q2 2021 | $128,000 | – | 6,985 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VR Adviser, LLC | 2,699,865 | $68,684,566 | 13.41% |
| COMMODORE CAPITAL LP | 2,189,659 | $55,704,925 | 8.48% |
| Fairmount Funds Management LLC | 1,369,623 | $34,843,209 | 5.99% |
| Paradigm Biocapital Advisors LP | 2,085,698 | $53,060,157 | 5.03% |
| Octagon Capital Advisors LP | 1,185,000 | $30,146,400 | 4.34% |
| Logos Global Management LP | 950,000 | $24,168,000 | 3.46% |
| TCG Crossover Management, LLC | 663,610 | $16,882,238 | 3.29% |
| ACUTA CAPITAL PARTNERS, LLC | 168,000 | $4,273,920 | 3.15% |
| Vivo Capital, LLC | 1,678,207 | $42,693,586 | 2.96% |
| TANG CAPITAL MANAGEMENT LLC | 692,925 | $17,628,012 | 2.63% |